Copyright © 2002 by the European Society of Cardiology.
Defining the optimum upper heart rate limit during exercise. A study in pacemaker patients with heart failure
a Department of Internal Medicine, Division of Cardiology and Angiology, Universitätskliniken des Saarlandes, Homburg/Saar, Germany
b Curschmann-Clinic for Cardiovascular Diseases, Timmendorfer Strand, Germany
revised October 30, 2001; accepted November 7, 2001
Abstract
Aims There is no non-invasive method to determine the individual optimum of maximum exercise heart rate. Knowledge of this value is of particular interest in patients with structural heart disease who are prone to tachycardia intolerance. The purpose of this study was to define the optimal maximum heart rate using cardiopulmonary exercise testing and exercise Doppler echocardiography and to compare the results of both approaches.
Methods and Results In 49 pacemaker patients with chronotropic incompetence, the optimum upper heart rate limit was determined using cardiopulmonary exercise testing and exercise Doppler echocardiography. The optimum upper rate limit was given by the highest pacing rate which still produced an increase in oxygen consumption, or by that pacing rate which was linked to the lowest value for the Doppler-derived myocardial performance index. In patients with normal left ventricular ejection fraction (
55%) the optimum upper rate limit was 86% of age-predicted maximum heart rate, in patients with left ventriuclar dysfunction (ejection fraction
45%) it was 75% of the age-predicted maximum rate (P=0·004). The optimum upper rate limit, as defined by cardiopulmonary exercise testing and exercise Doppler echocardiography, were closely correlated (P<0·0001) with a mean deviation of 6±6beats.min1.
Conclusion Cardiopulmonary exercise testing and exercise Doppler echocardiography are valuable tools which help to determine the optimum upper rate limit in order to avoid excess heart rates in heart failure patients. The application of these methods is not limited to pacemaker patients but may be helpful in therapeutic interventions with chronotropic drugs. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Key Words: Heart rate, exercise, heart failure, cardiac pacing
f1 Correspondence: Michael Kindermann, MD, Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, Kirrberger Straße, D 66421 Homburg/Saar, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U. P. Jorde, T. J. Vittorio, M. E. Kasper, E. Arezzi, P. C. Colombo, R. L. Goldsmith, K. Ahuja, C.-H. Tseng, F. Haas, and D. S. Hirsh Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: Time to pace? Eur J Heart Fail, January 1, 2008; 10(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Melzer, J. Witte, R. Reibis, H.J. Bondke, W. Combs, K. Stangl, G. Baumann, and H. Theres Predictors of chronotropic incompetence in the pacemaker patient population. Europace, January 1, 2006; 8(1): 70 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Tse, C.-W. Siu, K. L.F. Lee, K. Fan, H.-W. Chan, M.-O. Tang, V. Tsang, S. W.L. Lee, and C.-P. Lau The Incremental Benefit of Rate-Adaptive Pacing on Exercise Performance During Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2292 - 2297. [Abstract] [Full Text] [PDF] |
||||


